Literature DB >> 21777717

Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity.

Scott Y H Kim1, Paul S Appelbaum, H Myra Kim, Ian F Wall, James A Bourgeois, Bernard Frankel, Kevin C Hails, James R Rundell, Kathleen M Seibel, Jason H Karlawish.   

Abstract

BACKGROUND: Assessment of decision-making capacity is a common and important function of psychiatric consultants. However, the sources of variability in evaluators' judgments have not been well characterized.
OBJECTIVE: To examine the degree and potential sources of variability in the categorical capacity judgments of experienced psychiatrists.
METHOD: The setting was a study comparing the decision-making capacities of 188 persons with Alzheimer's disease to appoint a research proxy and to consent to two hypothetical randomized controlled trials for dementia (a new drug RCT and a neurosurgical RCT). We compared five experienced consultation psychiatrists' capacity judgments for 555 videotaped capacity interviews. Both quantitative and qualitative data were used.
RESULTS: Pair wise kappa statistics ranged from slight agreement (0.17) to substantial agreement (0.64) with group kappa statistics ranging from fair to moderate agreement (0.40 to 0.45) for the psychiatrists' judgments regarding the three capacities. The sources of variability included varying "strictness" among judges, moderate test-retest reliability within judges, the relative novelty of assessing decision-making capacity for research participation decisions, as well as the limitations of the methods used to obtain capacity judgments in the study. DISCUSSION: There is considerable variability in capacity judgments of experienced consultation psychiatrists regarding the capacities to appoint a research proxy and to consent to research. The potential sources of variability identified in this study may provide starting points for more effective training in capacity assessment.
Copyright © 2011 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21777717      PMCID: PMC3142349          DOI: 10.1016/j.psym.2011.01.012

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  19 in total

1.  Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.

Authors:  S Y Kim; E D Caine; G W Currier; A Leibovici; J M Ryan
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

2.  The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.

Authors:  Thomas Grisso; Paul S Appelbaum
Journal:  Law Hum Behav       Date:  1995-04

3.  Decisional capacity for informed consent in schizophrenia research.

Authors:  W T Carpenter; J M Gold; A C Lahti; C A Queern; R R Conley; J J Bartko; J Kovnick; P S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2000-06

4.  Consistency of physician judgments of capacity to consent in mild Alzheimer's disease.

Authors:  D C Marson; B McInturff; L Hawkins; A Bartolucci; L E Harrell
Journal:  J Am Geriatr Soc       Date:  1997-04       Impact factor: 5.562

5.  Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard.

Authors:  D C Marson; H A Cody; K K Ingram; L E Harrell
Journal:  Arch Neurol       Date:  1995-10

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

Authors:  M P Dymek; P Atchison; L Harrell; D C Marson
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  Preservation of the capacity to appoint a proxy decision maker: implications for dementia research.

Authors:  Scott Y H Kim; Jason H Karlawish; H Myra Kim; Ian F Wall; Andrea C Bozoki; Paul S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2011-02

9.  Capacity to provide informed consent for participation in schizophrenia and HIV research.

Authors:  David J Moser; Susan K Schultz; Stephan Arndt; Michelle L Benjamin; Frank W Fleming; Colleen S Brems; Jane S Paulsen; Paul S Appelbaum; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

10.  Decisional capacity of severely depressed patients requiring electroconvulsive therapy.

Authors:  Maria I Lapid; Teresa A Rummans; Kristine L Poole; V Shane Pankratz; Megan S Maurer; Keith G Rasmussen; Kemuel L Philbrick; Paul S Appelbaum
Journal:  J ECT       Date:  2003-06       Impact factor: 3.635

View more
  12 in total

Review 1.  The ethics of informed consent in Alzheimer disease research.

Authors:  Scott Y H Kim
Journal:  Nat Rev Neurol       Date:  2011-05-24       Impact factor: 42.937

2.  Ethics of clinical research with mentally ill persons.

Authors:  Hanfried Helmchen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-01-03       Impact factor: 5.270

3.  Research consent capacity varies with executive function and memory in Parkinson's disease.

Authors:  Stephen T Moelter; Daniel Weintraub; Lauren Mace; Mark Cary; Elizabeth Sullo; Sharon X Xie; Jason Karlawish
Journal:  Mov Disord       Date:  2016-02-10       Impact factor: 10.338

4.  Multimedia Aided Consent for Alzheimer's Disease Research.

Authors:  Barton W Palmer; Alexandrea L Harmell; Laura B Dunn; Scott Y Kim; Luz L Pinto; Shahrokh Golshan; Dilip V Jeste
Journal:  Clin Gerontol       Date:  2017-11-28       Impact factor: 2.619

Review 5.  Informed Consent to Research with Cognitively Impaired Adults: Transdisciplinary Challenges and Opportunities.

Authors:  Beth Prusaczyk; Steven M Cherney; Christopher R Carpenter; James M DuBois
Journal:  Clin Gerontol       Date:  2016-06-20       Impact factor: 2.619

6.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

Review 7.  Determining medical decision-making capacity in brain tumor patients: why and how?

Authors:  Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven
Journal:  Neurooncol Pract       Date:  2020-07-16

8.  Consent processes in cluster-randomised trials in residential facilities for older adults: a systematic review of reporting practices and proposed guidelines.

Authors:  Karla Diazordaz; Anne-Marie Slowther; Rachel Potter; Sandra Eldridge
Journal:  BMJ Open       Date:  2013-07-08       Impact factor: 2.692

9.  Research involving subjects with Alzheimer's disease in Italy: the possible role of family members.

Authors:  Corinna Porteri; Carlo Petrini
Journal:  BMC Med Ethics       Date:  2015-03-04       Impact factor: 2.652

10.  Assessing children's competence to consent in research by a standardized tool: a validity study.

Authors:  Irma M Hein; Pieter W Troost; Robert Lindeboom; Martine C de Vries; C Michel Zwaan; Ramón J L Lindauer
Journal:  BMC Pediatr       Date:  2012-09-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.